Sanofi’s Tzield (teplizumab) has received expanded approved from the US FDA, allowing it to be used for children aged one ...

Helus Pharma, a clinical stage pharmaceutical company committed to helping minds heal by developing novel serotonergic ...

AI is fundamentally changing the way marketing operates omnichannel journeys, enabling true next-best communication ...

Merck’s Enflonsia (clesrovimab) has been approved by the European Commission for the prevention of respiratory syncytial ...

AstraZeneca has reported positive high-level results from the phase 3 MIRANDA trial of tozorakimab, showing a statistically ...

Launching a new therapy is an uphill battle for emerging biopharma, with limited budgets and human resources. Yet in 2025, ...

Explore real patient conversations about weight loss drugs, uncovering challenges, support strategies, and the critical need ...

Behaviour change is not primarily a matter of information or intention, but of habit, environment, identity and reward ...

Eli Lilly has agreed to acquire Kelonia Therapeutics in a deal valued at up to $7bn, as the company looks to expand its ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation to Biogen for a ...

In our cover story this month, Danny Buckland looks at weight loss medication and how GLP-1s have been shown to provide game-changing opportunities for patients who are overweight or obese to improve ...

Icotyde (icotrokinra) has been approved by the US FDA to treat moderate-to-severe plaque psoriasis (PsO) in both adults and ...